An Evaluation of Provider-Sharing Networks of Patients Using Prescription Opioids by Aroke, Hilary A.
University of Rhode Island 
DigitalCommons@URI 
Open Access Master's Theses 
2018 
An Evaluation of Provider-Sharing Networks of Patients Using 
Prescription Opioids 
Hilary A. Aroke 
University of Rhode Island, aharoke@gmail.com 
Follow this and additional works at: https://digitalcommons.uri.edu/theses 
Recommended Citation 
Aroke, Hilary A., "An Evaluation of Provider-Sharing Networks of Patients Using Prescription Opioids" 
(2018). Open Access Master's Theses. Paper 1867. 
https://digitalcommons.uri.edu/theses/1867 
This Thesis is brought to you for free and open access by DigitalCommons@URI. It has been accepted for inclusion 
in Open Access Master's Theses by an authorized administrator of DigitalCommons@URI. For more information, 
please contact digitalcommons@etal.uri.edu. 
 
AN EVALUATION OF PROVIDER-SHARING NETWORKS OF PATIENTS 
USING PRESCRIPTION OPIOIDS 
BY 





A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE 
REQUIREMENTS FOR THE DEGREE OF 




































Major Professor Natallia V. Katenka 
 
   Ashley L. Buchanan 
 
   Prabhani Kuruppumullage Don 
    
   Stephen S. Kogut 
 
     
      Nasser H. Zawia 
 












IMPORTANCE: Patients using prescription opioid are embedded in a network due 
provider-sharing and living in the same community. As a result, they may exert 
influence on each other’s treatment preferences and share attitudes towards 
prescription opioid use and misuse. 
OBJECTIVE: To determine patient characteristics associated with the observed 
pattern of shared prescribers in a network and identify influential patients in the 
network.  
DESIGN, SETTING, AND PARTICIPANTS: We conducted a cross-sectional 
network-based study using the Rhode Island (RI) Prescription Drug Monitoring 
Program (PDMP) data for the 2015 calendar year. All patients who filled at least one 
opioid prescription at a retail pharmacy were eligible. The analysis was limited to 
patients who were on a stable opioid regimen and used only one source of payment, 
and filled only one type of opioid medication (oxycodone, hydrocodone or 
buprenorphine/naloxone) from ≥ 3 prescribers, and visited ≥ 3 pharmacies during the 
year. To minimize the influence of less relevant network connections, we excluded 
institutional providers and providers who issued opioid prescriptions to ≤ 6 patients. 
We applied social network analysis (SNA) methods to a sample of 372 patients 
connected to each other through provider-sharing. We used the exponential random 
graph model (ERGM) assuming conditional dyadic independence to examine the 
relationship between patient attributes and the likelihood of forming network ties. 
Homophily was defined as the tendency of patients to associate with others who have 
similar characteristics. Three centrality measures (degree, closeness, and betweenness) 
 
were used to identify patients with potential influence in the opioid prescription 
network.  
MAIN OUTCMES AND MEASURES: We provide a visual and descriptive 
characterization of the network, used centrality measures to identify influential 
patients, and ERGM to assess homophily and differential homophily.  
RESULTS: The mean age of patients included in the analysis was 51 years; 53% 
were female; 57% took oxycodone, 34% took hydrocodone and 9% took 
buprenorphine/naloxone. On average, 53% of patients received less than 50 morphine 
milligram equivalents (MME) daily, and the mean (standard deviation [SD]) number 
of opioid prescriptions per patient was 14.4 (6.6). Sixty-four percent of patients had 
commercial insurance, 28% had Medicaid, 5% had Medicare, and almost 2.5% used 
cash payment only. All three centrality measures were in agreement on the 
identification of the most influential patient in the opioid prescription network but 
overall correlation between the measures was low. After controlling for the main 
effects in the ERGM model, homophily was associated with age group, method of 
payment, number and type of opioid prescription filled, mean daily MME, and number 
of providers seen. 
CONSLUSIONS: Characteristics of patients in an opioid prescription network may 
influence which provider they choose and which patients they are connect to through 
provider sharing. Interventions targeted at influential patients in the network may have 
potential to influence social norms around the use and misuse of prescription opioids 
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This thesis is written in the manuscript format, and is comprised of a single 
manuscript, which applied network analysis to advance our understanding of an opioid 
prescription network in the state of Rhode Island. We propose approaches to identify 
and target influential patients for interventions to alter social norms around opioid 
misuse. Its focus is on the application of the methods and it is written for a non-
statistical audience. A more statistical discussion of essential concepts is presented in 
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IMPORTANCE: Patients using prescription opioid are embedded in a network due to 
provider-sharing and living in the same community. As a result, they may exert 
influence on each other’s treatment preferences and share attitudes towards 
prescription opioid use and misuse. 
OBJECTIVE: To determine patient characteristics associated with the observed 
pattern of shared prescribers in a network and identify influential patients in the 
network.  
DESIGN, SETTING, AND PARTICIPANTS: We conducted a cross-sectional 
network-based study using the Rhode Island (RI) Prescription Drug Monitoring 
Program (PDMP) data for the 2015 calendar year. All patients who filled at least one 
opioid prescription at a retail pharmacy were eligible. The analysis was limited to 
patients who were on a stable opioid regimen and used only one source of payment, 
and filled only one type of opioid medication (oxycodone, hydrocodone or 
buprenorphine/naloxone) from ≥ 3 prescribers, and visited ≥ 3 pharmacies during the 
year. To minimize the influence of less relevant network connections, we excluded 
institutional providers and providers who issued opioid prescriptions to ≤ 6 patients. 
We applied social network analysis (SNA) methods to a sample of 372 patients 
connected to each other through provider-sharing. We used the exponential random 
graph model (ERGM) assuming conditional dyadic independence to examine the 
relationship between patient attributes and the likelihood of forming network ties. 
Homophily was defined as the tendency of patients to associate with others who have 
similar characteristics. Three centrality measures (degree, closeness, and betweenness) 
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were used to identify patients with potential influence in the opioid prescription 
network.  
MAIN OUTCMES AND MEASURES: We provide a visual and descriptive 
characterization of the network, used centrality measures to identify influential 
patients, and ERGM to assess homophily and differential homophily.  
RESULTS: The mean age of patients included in the analysis was 51 years; 53% 
were female; 57% took oxycodone, 34% took hydrocodone and 9% took 
buprenorphine/naloxone. On average, 53% of patients received less than 50 morphine 
milligram equivalents (MME) daily, and the mean (standard deviation [SD]) number 
of opioid prescriptions per patient was 14.4 (6.6). Sixty-four percent of patients had 
commercial insurance, 28% had Medicaid, 5% had Medicare, and almost 2.5% used 
cash payment only. All three centrality measures were in agreement on the 
identification of the most influential patient in the opioid prescription network but 
overall correlation between the measures was low. After controlling for the main 
effects in the ERGM model, homophily was associated with age group, method of 
payment, number and type of opioid prescription filled, mean daily MME, and number 
of providers seen. 
CONSLUSIONS: Characteristics of patients in an opioid prescription network may 
influence which provider they choose and which patients they are connect to through 
provider sharing. Interventions targeted at influential patients in the network may have 
potential to influence social norms around the use and misuse of prescription opioids 





Questions: What patient characteristics explain the pattern of shared-provider 
connections among patients in an opioid prescription network and can we identify 
influential patients as potential targets for opioid misuse prevention interventions? 
Findings: In this social network analysis of PDMP data, we found extensive 
homophily that was associated with age group, method of payment, number and type 
of opioid prescription filled, mean daily dose, and number of prescribers ordering 
opioid prescriptions. All three commonly used centrality measures identified the same 
individual as the most influential patient in the network. 
Meaning: Some patients in an opioid prescription network occupy influential 
positions through a large number of shared providers or by virtue of their location on 
paths between other patients in the network. Patients with similar characteristics tend 
to share providers with each other. These findings suggest that interventions targeted 
at influential, well-connected patients in the network may alter social norms around 












The United States is experiencing an unprecedented prescription opioid overdose 
crisis driven in part by few patients who possibly engage in doctor shopping which 
may be identified in this context as patients obtaining opioid prescriptions from 
multiple providers without the prescribers’ knowledge of other opioid prescriptions.1-3 
Prescribers may be sought by patients using opioids because of their reputation around 
opioid prescribing patterns such as use of high daily dose, use of combination opioids, 
and frequent refills. Knowledge about individual prescriber clinical practices and 
preferences may be shared among patients during co-visitation or social encounters in 
the community. A recent study demonstrated that health care providers tended to share 
patients with providers who have similar patients in their practice.4  This suggests that 
patients prescribed opioids in a single state could be conceptualized as a network of 
patients with connections through shared providers which we define in an opioid 
prescription network. We hypothesized that patients within an opioid prescription 
network may exert influence on each other’s opioid prescription utilization, including 
opioid misuse as a result of living in the same community or sharing a common opioid 
prescriber in the network, thereby impacting their network member’s opioid 
prescription utilization and social norms around opioid use and misuse.5  
Limited data suggests that a few high-intensity prescribers play a central role 
in sustaining the prescription opioid epidemic.6,7 The pattern of provider-sharing may 
help identify corresponding influential or central patients in a network, thereby 
providing a clearer picture of where doctor shopping for prescription opioids may be 
occurring. This understanding can inform the implementation of targeted interventions 
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designed to improve prescription opioid utilization, prevent misuse, and treat opioid 
use disorder among patients in a network. A network-based perspective has been used 
to study a wide range of relational processes involving the flow of information 
between network members connected to each other in a social network. This 
perspective provides a framework that can be used to understand the structure of a 
network and how it influences the behavior of individual members in the network.8-10 
Landon et al. recently used network-based methods to demonstrate that characteristics 
of patient-sharing networks and the position of providers in the network are associated 
with healthcare resource utilization and cost.11 Another study used network analysis to 
show racial differences in referral patterns for total hip replacement between 
communities with low and high concentrations of back residents.12 Similar studies 
have not been done using an opioid prescription network. 
There is a dearth of knowledge about characteristics of patients possibly 
engaged in doctor shopping for opioid prescriptions and methods to identify 
prescription opioid doctor shopping behavior are limited. To the best of our 
knowledge, network analysis has not yet been used to study an opioid prescription 
network within any state. The purpose of this study was to explore and characterize a 
patient-based opioid prescription network using social network analysis (SNA) 
methods. Specifically, we described patterns of relationships between patients within 
an opioid network, identified patients who have an influential role in the network, and 
examined patient characteristics that may explain the observed pattern of provider-
sharing relationships. We used the exponential random graph model (ERGM) 
assuming conditional dyadic independence to examine the influence of some 
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characteristics of individual patients in the network on their likelihood to form 
network connections through provider sharing.  
BACKGROUND 
Over the past three decades opioid prescribing has increased tremendously in the 
United States, with a corresponding rise in opioid misuse and opioid overdose-related 
deaths.13,14 An important feature of this opioid epidemic is the association between 
increasing rates of opioid prescribing and opioid-related morbidity and mortality.15-17 
Among people who died of opioid overdoses, up to 66% used prescription opioid 
analgesics originally prescribed for someone else; with doctor shopping being an 
important means for acquiring these prescription opioids for misuse.18-24 In one study 
designed to determine the prevalence of doctor shopping for different controlled 
substances, prescription opioid medications (12.8%) were the most frequently 
involved, followed by benzodiazepines (2.4%), and stimulants (1.4%).25 A cross-
sectional study of French patients on buprenorphine maintenance treatment identified 
opioid misuse as a significant problem.3 Similar findings were reported in a review of 
buprenorphine misuse.26 Doctor shopping for prescription opioid medications often 
precedes fatal overdose, and accounts for about 40% of opioid-related overdoses, and 
up to 30% of deaths.18,27-30 According to data from the Rhode Island Department of 
Health, overdose deaths increased by more than 90% between 2011 and 2016. There 
were 426 overdose deaths, of which 32% were related to fentanyl products, about 70% 
were males, and 25% were in their 50s.31  
In response to the epidemic of opioid misuse, state-run Prescription Drug 
Monitoring Programs (PDMPs) were implemented in 49 states. These electronic 
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databases collect information on controlled substance prescriptions including opioid 
prescriptions, regardless of the sources of payment. These databases have been used 
by prescribers and others to examine filling patterns consistent with prescription 
opioid shopping behavior and potential misuse.32-34 The number of providers involved 
in the care of a patient is often considered to be one of the strongest predictors of 
potential opioid misuse because until recently providers often did not have ready 
access to complete and accurate medication history at time of opioid prescribing.35-41 
The use of the number of prescribers to fill controlled substances, referred to as 
multiple prescriber episodes (MPE), has frequently been used as an indicator of doctor 
shopping in PDMP databases. The absence of a universally accepted definition for a 
threshold has led to wide variations in national estimates of doctor shopping, and 
associated difficulties in making comparisons across different settings to evaluate the 
effectiveness of interventions to prevent or reduce prescription opioid doctor shopping 
behavior.18,32,34,42 We sought to evaluate the influence of MPE, number of opioid 
prescriptions, number of pharmacies used, method of payment, age group,  and gender 
on the likelihood to form network connections through provider sharing. 
Standard statistical approaches often assume independence of patients and/or 
providers and ignore contextual relationships between providers and patients, and 
among patients due geographic proximity, social influence, and local medical practice 
norms; thereby, limiting our ability to evaluate prescription opioid doctor shopping 
behavior. The goal of this study was to incorporate relational information using SNA. 
These findings will better inform future intervention policies designed to improve 
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social norms around prescription opioid use and prevent potential misuse among 
patients within a community of patients using prescription opioids.  
METHODS 
Data source: We conducted a cross-sectional network-based study using the Rhode 
Island (RI) PDMP data for the 2015 calendar year when the opioid crisis was a major 
statewide concern to patients, prescribers and public health regulators. The 2015 data 
contains records of schedule II to IV controlled substances dispensed by all retail 
pharmacies in the state. It includes de-identified unique patient, prescriber, and 
dispensing pharmacy information, and a limited number of variables such as age (in 
years) and sex of the patient, National Drug Code (NDC), product name, strength, 
formulation, and therapeutic class code of the drug plus number of days’ supply, 
metric quantity dispensed, method of payment, and the date each prescription was 
filled. Daily morphine milligrams equivalents (MME) were estimated using standard 
conversion factors published by the Center for Disease Control and Prevention. 
Cohort selection: A total of 2,058,816 controlled substance prescriptions were 
dispensed in RI in 2015 including opioid analgesics, benzodiazepines, 
psychostimulants, skeletal muscle relaxants, and sleep aids.43 Unique NDC codes were 
used to identify 809,195 schedules II-IV opioid prescriptions filled at retail 
pharmacies by 222,513 patients (Figure 1). To minimize the impact of less clinically 
relevant network connections, we excluded institutional providers and prescribers who 
issued opioid prescriptions to ≤ 6 patients during the study year. An institutional 
provider was defined as any prescriber who had more than 2,400 patients on opioid 
prescriptions medications per year attributed to their Drug Enforcement 
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Administration (DEA) number. Institutional DEA numbers are used by medical 
students and residents to prescribe controlled substances under the supervision of a 
licensed attending physician. Patients were required to have used only one type of 
opioid medication and one source of payment method during the study period in order 
to capture patients who were more likely on a stable pain management regimen and to 
facilitate meaningful interpretation of the impact of these patient attributes. We limited 
our analysis to commonly used and misused types of opioid medications (i.e., 
oxycodone and hydrocodone), and buprenorphine/naloxone that is used to treat opioid 
use disorders. We hypothesized that patients on buprenorphine/naloxone for opioid 
use disorders would connect to one another more often than expected by chance.  In 
addition, we restricted our analysis to patients who saw ≥ 3 prescribers for the same 
opioid prescription and filled their opioid prescriptions at ≥ 3 pharmacies within one 
year in order to capture patients with meaningful involvement in the patient-based 
opioid prescription network. Multiple visits allow the network to capture relationships 
between patients using opioid prescriptions. Several studies have used higher 
thresholds of 4 or 5 to flag doctor/pharmacy shopping behavior when applied to 
multiple types of opioid prescription per patient.42,44 We evaluated the influence of age 
or age category, sex, source of payment, and type of opioid medication, number of 
opioid prescriptions, average daily MME, number of providers, and number of 
pharmacies on the likelihood of having a network connection defined by having one or 





Network-based framework  
A network may be defined as a collection of points (i.e., vertices, nodes) and lines 
(i.e., edges, ties, links, connections) joining them. In a social network, these vertices 
represent people or groups of people and edges represent a kind of interaction between 
them. PDMP data links each patient who received at least one opioid prescription to 
one or more providers who ordered the opioid prescription(s). The receipt of one or 
more opioid prescriptions from a prescriber was used as a proxy for a relationship or 
interaction between a patient and a provider because state regulation requires a 
physician visit for a written opioid prescription. These prescription records were used 
to create an edge list, a two-column table, mapping patients to providers, each row 
representing an individual opioid prescription. The edge list was used to create a 
bipartite (two-mode) network where all pairs of patients and providers are joined by 
an edge. The bipartite network was represented as a provider-by-patient incidence 
matrix with cell entries indicating whether a provider wrote an opioid prescription to a 
particular patient (Figure 2). The rows of the matrix consisted of individual patients 
and columns identified providers. Pre-multiplying the bipartite incidence matrix by its 
transpose gave a symmetric unipartite (one-mode) adjacency matrix with either 
providers or patients only. The diagonal elements of the unipartite square matrix 
corresponded to the number of providers who wrote at least one opioid prescription to 
a given patient while the off-diagonal elements indicate the number of providers any 
two patients had in common. This analysis focused on the patient-based network 
where all nodes are represented by patients and connections (or edges) correspond to 
shared-provider relationships. To avoid the creation of loops and multi-edges, 
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diagonal elements were set to zero and off-diagonal elements with values greater than 
one were set to 1, respectively. The construction of a simple patient-based network 
graph is illustrated in Figure 3.  
Network visualization: Network visualizations were selected to optimally place 
nodes in positions that visually convey important information in the network, such as 
the overall structure, location of influential patients in the network, and the presence of 
distinctive subgroups (or clusters within the network).45,46 Some patient characteristics 
were incorporated into visualizations using different node colors. Graphical 
representation was used to examine degree, triangles, dyad-wise shared partners 
(DSP), and edgewise shared partners (ESP) distributions to explore the network in 
order to understand its structures. A DSP is a linked or unlinked dyad (i.e., patient 
pair) where both patients are linked to a third network member. ESP is a linked dyad 
in which both patients of the dyad are linked to a third network member. The 
distribution of ESP in a network was used to show how many dyads had one shared 
partner, two shared partners, and so on. Similarly, the distribution of DSP was used to 
show the number of dyads in the network with one shared partner, two shared 
partners, and so on. Node degree and triangles are defined below. 
Network description: We evaluated the network with basic description of the 
network size, density, and number of components, diameter, clustering, centrality and 
modularity. The network size is defined as the number of nodes (i.e., patients) in the 
network and its density is defined as the proportion of observed connections in the 
network to the maximum number of possible connections in a randomly-generated 
network of the same size. A path is a series of steps required to go from patient A to 
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patient B. The shortest path is called the geodesic (distance) and the longest path is its 
diameter. A component is a subgroup of patients in the network such that there is a 
path connecting any two patients in the component directly or indirectly. A network is 
said to be connected if all pairs of nodes are connected directly or indirectly. When the 
largest connected component (LCC) is much bigger than the other components in a 
network it is called the giant component. The LCC was used to improve visualization, 
apply centrality measures, and develop ERGM models.  
Global clustering measures the tendency of a network to form closed triangles 
(i.e., connections between three patients). A triangle closes when three patients share 
an opioid prescriber. Transitivity or clustering coefficient is the proportion of paths of 
length two that are closed. For each patient, it refers to the ratio of the total number of 
connections that exist among neighbors of the patient in the network to the total 
number of possible connections that could exist if they were completely connected.47  
This local clustering coefficient describes the extent to which network neighbors of a 
particular patient are directly connected to each other and may be interpreted as the 
probability that any two randomly selected neighbors of a particular patient in the 
network are connected to each other. Lower local clustering coefficients indicate 
fewer structural holes in the network and greater patient centrality.47,48 
Network measures of centrality attempt to determine which patients are the 
most influential or central persons in a network.47 The influence of an individual 
patient on others in a network through dissemination of information may influence 
social norms around opioid misuse and the sharing of opioid prescriptions in the 
network. In general, we expect patients with more connections to exert greater 
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influence on others in the network by sharing their attitudes towards opioid 
prescription use with a wider group of patients. We employed three commonly used 
centrality measures: degree, closeness, and betweenness centralities. Firstly, a 
patient’s degree centrality is the number of other patients with direct connections to 
the patient or simply the number of shared providers. Secondly, closeness centrality 
measures how close a patient is to every other patient in the network, and reflects how 
fast information and influence of a particular patient can disseminate to other patients 
in the network. Formally, it is the inverse of the sum of all distances between patient  
and all other patients in the network. Thirdly, betweenness centrality measures the 
extent to which a patient acts as a bridge between pairs of other patients in the network 
to facilitate the flow of information through the network. This implies that patients 
with larger betweenness centralities are more likely to have contacts with many other 
patients and may have greater influence regarding social norms around the use and 
potential misuse of prescription opioids in the network.49,50 To estimate this measure, 
we used a commonly applied algorithm proposed by Freeman.51 The most influential 
patient in the network was identified using each centrality measure and a subgraph 
corresponding to that individual and his or her immediate neighborhood was 
constructed.52  
The LCC was used to calculate centrality measures that were standardized for 
comparison. Degree and closeness centralities were standardized dividing the estimate 
by their maximum possible values,  and , respectively, while the 
betweenness was normalized by dividing through the number of pairs of vertices not 
including the index vertex, . A chi-squared test was used to 
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compare the distribution of patient attributes across tertiles of the standardized 
centrality measures in the LCC. Assuming standardized centrality measures are 
independent and identically distributed across patients, three separate multivariable 
logistic regression models were fit to predict membership in the highest tertile of the 
standardized centrality measure. We used Pearson’s correlation coefficient and 28 
(10%) patients with the highest values for each standardized centrality measure to 
assess the level of agreement in identifying the most influential patients. 
Modularity, a chance-corrected statistic, is defined as the proportion of 
connections that fall within observed groups based on patient characteristics minus the 
expected proportion if the connections were randomly distributed. The scores ranges 
from  to  and the closer the score value is to 1, the more the network exhibits 
clustering with respect to the grouping factor. Modularity scores were used to examine 
the influence of patient characteristics on patterns of connections in the opioid 
prescription network. Furthermore, because network visualization and modularity 
showed some evidence of clustering, mixing matrices and Pearson’s correlation were 
examined. Mixing matrices were used to examine the number of connected dyads for 
each possible combination of levels of categorical patient characteristic. These 
exploratory analyses identified patient characteristics that were included in the ERGM.  
Statistical network modeling: ERGMs were used to estimate the influence of 
covariates on the likelihood of ties in the opioid prescription network. This class of 





where,  is the random set of relationships (edges and non-edges) in a network,  is 
the observed set of relationships,  is a matrix of attributes for the vertices in that 
network,  is a vector of the network statistics,  is the vector of coefficients, 
and  is a normalizing constant. Alternatively, the model states that the log odds 
for any given edge to exist conditional on the remaining network connections, and can 
be written as: 
, 
where,  is an indicator for a connection between pairs of patients in Y, and 
  is the change in  value as  is toggled from 0 to 1 (See 
Technical Appendix for details).  
We first modeled a simple random graph (i.e., null model) which contained 
only an edges term to capture the network density.53 A simulated network of the same 
size and density as the observed opioid prescription network was compared to the 
observed network in order to identify important differences between the two networks. 
The main effects and pairwise homophily interaction terms were added sequentially to 
the null model to represent attributes of patients in the network. Homophily was 
defined as the tendency for patients to connect with others like themselves. To 
examine the influence of node attributes on the likelihood of having a shared provider 
in the network, patient attributes were added to the model as main effects. We 
hypothesized that specific patient attributes, including number of opioid prescriptions, 
sex, age group, type of insurance coverage, type of opioid prescription, number of 
prescribers and pharmacies, explain the pattern of patient connections through 
provider sharing.  
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Homophily or assortative mixing is a tendency of patients to associate with similar 
patients, while disassortative mixing is the tendency to associate with dissimilar 
patients. Two types of dyadic interaction terms were added to the main effects model 
to assess assortative and disassortative mixing in the network leading to patterns of 
homophily or heterophily, respectively. First, we assessed the likelihood of provider 
sharing when both patients in a dyad had the same level of a categorical attribute. The 
number of opioid prescriptions was added as a continuous attribute. We hypothesized 
that two patients with a similar number of opioid prescriptions filled during the study 
year were more likely to form a network connection based on having a shared 
provider. Secondly, we assessed the likelihood of provider sharing when both patients 
in a dyad had different levels (i.e., dissimilar) of a categorical attribute such as type of 
opioid prescription (differential homophily).  
We limited this analysis to ERGM models that assume dyadic independence of 
network connections.54 This assumption specified that patients sharing a provider were 
dependent but independent if they had no provider in common. The null and main 
effects models with and without homophily and differential homophily terms were 
compared using Log L and related measures of deviance (-2LogL), the Akaike 
information criterion (AIC) and the Bayesian information criterion (BIC).55,56 All tests 
of statistical significance were two-sided and performed at the 0.05 significance level. 
Data manipulation was performed with SAS, version 9.4 (SAS Institute, Cary, NC) 
and network analysis was implemented with R statistical software, version 3.2.3 (R 
Core Team 2016). The study was approved by the Institutional Review Board at 




A total of 372 patients prescribed opioids by 746 providers during a one-year study 
period met the inclusion criteria for meaningful involvement in the opioid prescription 
network in RI. Table 1 presents a summary of the characteristics of all the patients 
compared to those in the LCC. The mean (SD) age of all patients in the sample was 51 
(14) years with 50% aged 45-64 years, and 53% were female. More than 5,000 opioid 
prescriptions were filled, of which 57% were prescriptions for oxycodone, 34% were 
for hydrocodone and 9% were for buprenorphine/naloxone. The mean number of 
opioid prescriptions filled per patient was 14.4 (SD=6.6) with 53% receiving on 
average less than 50 MME daily. However, 25% of patients had on average more than 
90 MME per day. Most patients paid for all their opioid prescriptions with commercial 
insurance and only 2.4% used cash payment exclusively. About half of the patients 
filled opioid prescriptions written from ≥4 prescribers while 31% filled their opioid 
prescriptions at ≥4 pharmacies during the one-year study period.  
Network characteristics: The bipartite network had a total of 1,118 nodes (746 
providers plus 372 patients) with 1,460 unique connections between them 
corresponding to unique patient-provider relationships resulting from one or more 
opioid prescriptions. There were more prescribers in the network than patients. The 
overall bipartite density was only 0.5%. The full opioid network contained 372 
patients with 1,980 connections among them; 32 (8.6%) had no shared providers 
(isolates) [Figure 4]. The full network had 55 connected components including 32 
isolates, and the LCC contained 74% of all the patients in the network including 
95.66% of all connections; the second largest connected component consisted of only 
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2.4% (Figure 5). The full network and its LCC demonstrated apparent clustering with 
at least 4-5 large clusters. There was some evidence of clustering by age group, opioid 
type, average daily dose, and method of payment; however, no pattern by gender was 
apparent. The most obvious clustering is seen among patients who were on 
buprenorphine/naloxone. One possible explanation for this clustering is that under the 
Drug Addiction Treatment Act (DATA) of 2000, only certain qualified providers are 
authorized to prescribe buprenorphine/naloxone as medication-assisted treatment for 
people diagnosed with an opioid use disorder. 
Characteristics of the full opioid network and its LCC are presented in Table 2. 
The LCC had an overall density of 5% compared with 3% for the whole network. The 
average number of shared providers was higher among those in the LCC (13.8) 
compared to the whole network (10.6). The average path length and longest path were 
the same (≈ 10) suggesting that the rate of flow of information diffusion in the LCC 
would be similar to that of the full network. However, the density around the most 
central patient was 65%, average number of shared providers was 25 (SD=9) and the 
average path length only 1.4 (Figure 6). Assortative mixing and the fraction of 
transitive triples (transitivity) were higher for the whole cohort. About 85% of patients 
who shared a provider were connected to other patients who also shared a provider 
with each of them. Seventy-five of patients were connected to one or more patients 
with at least one similar characteristic.  
 The number of shared providers was quite heterogeneous across patients 
(Figure 7). While there are many patients with few shared providers, there was a non-
trivial number with many shared providers. In particular, there are 28 patients with 29 
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shared prescribers. This may correspond to providers in the same practice or on-call 
group. Given the nature of the decay in the degree distribution, a log-log scale was 
used to assess the results. The middle panel in Figure 7 shows a somewhat linear 
decay in the log-frequency as a function of the log-degree. A plot of the average 
neighbor degree versus vertex degree suggests that while there is a tendency for 
patients with many shared providers to connect to each other, those with fewer shared 
providers tend to connect with both patients having lower and higher number of shared 
providers (assortative degree network). This is illustrated by the high network density 
around the most influential patient (Figure 6). 
Centrality measures: Overall, there was moderate correlation between degree and 
closeness (r = 0.53; p < 0.001), and between closeness and betweenness(r = 0.48; p < 
0.001) centralities. However, correlation between degree and betweenness centralities 
was low (r = 0.19; p=0.002).  Among 56 patients with the highest standardized 
centrality values for any of the three measures, 14 (25%) were identified by degree 
and closeness centralities, 12 (21%) by closeness and betweenness centralities, 7 
(12%) by degree and betweenness centralities, and only 5 (8.93%) by all three 
measures. However, all three measures identified the same patient as the most 
influential patient in the network; a 48-year-old female on Medicare taking 
Oxycodone who filled 19 prescriptions for an average daily MME > 90 and saw 5 
different providers and visited 5 different pharmacies during one calendar year (data 
not shown).  
Tertiles of standardized centrality measures estimated from the LCC are 
presented in Table 3. Age group, type of opioid used, average daily dose, and number 
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of opioid prescribers were associated with at least one standardized centrality measure 
while gender, method of payment, and number of pharmacies were not associated with 
any centrality measure. Based on multivariable logistic regression model, age group, 
type of opioid used, average daily dose, and number of opioid prescribers were 
associated with the highest tertile of at least one standardized centrality measure, after 
adjusting for other covariates in the model (Table 4). Patients aged 45-64 years were 
most likely to be classified as having the highest levels of standardized degree 
centrality tertile as compared to those ages 65 years and older. Furthermore, patients 
who took on average > 90 daily MME were 6.7 times more likely to have the highest 
standardized degree centrality tertile compared to those on < 50 MME per day. This 
suggests that patients on higher daily doses of opioids tend to have more shared 
providers. Based on standardized closeness and betweenness centralities, patients who 
had ≥ 4 providers were more likely to be classified in the highest tertile of their 
respective standardized centrality measures. As compared with patients on 
hydrocodone, patients on buprenorphine/naloxone were less likely to be in the highest 
standardized degree centrality tertile and more likely to be in the highest standardized 
betweenness centrality tertile. This suggests that patients with few connections may be 
crucial for the diffusion of information and prescription opioids in the network.  
Network connectivity: Graphical examination of triangles, degree, DSP, and ESP were 
used to understand the network structure (Figure 8). The observed LCC of the network 
had many more completed triples than a randomly-generated network of the same size 
and density. Similarly, the LCC had many patients with few shared providers (low-
degree nodes) and few patients with many shared providers (high-degree nodes) 
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compared with a random network of the same size and density. Edgewise and dyad-
wise shared partner distributions also differed in the observed LCC and random 
networks with the observed LCC having more patients with multiple ESP and DSP 
compared with the random network, which indicated a large number of patients with 
one or two shared partners, and hardly any higher level multiples.  
Mixing matrices is presented in Table 5. Provider sharing tended to be between 
two patients who are both female, one younger and the other middle-aged, both on 
commercial insurance, both on oxycodone, one on low-dose and the other on 
intermediate daily dose, or both with 4 or more opioid prescribers. For example, of 
825 connected pairs of patients who took hydrocodone in opioid type mixing matrix, 
659 (80%) are connected to a patient who took only hydrocodone. This suggested a 
higher likelihood of patients who took hydrocodone to share providers with other 
patients who also took hydrocodone (i.e., homophily of opioid prescribing). From 
Table 6 opioid type, number of providers, average daily MME and age group had the 
highest modularity score and may explain some of the clustering observed in the 
network. From the perspective of the network connections and patient attributes, the 
GC was a reasonable representation of the full opioid prescription network.  
Results from ERGMs: Based on a null model with only the edge term to account for 
the number of connections in the network, the probability of a connection between any 
randomly selected two patients was 0.06 (i.e., density of the network). This baseline 
model was compared to models with more constraints. Although the null model 
provided a reasonable representation of the observed network density, it failed to 
represent other features of the network such as transitivity. A plot of 1,000 simulated 
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networks of the same size and density as the null model was used to assess how well 
the null model captured transitivity. The point on the x-axis in Figure 9 corresponds to 
the location of 12,514 triangles in the observed patient network, which was much 
higher than the number of triangles in any of the 1,000 simulated networks. This 
suggested that a more complex model with constraints on the number of triangle was 
needed to capture transitivity and other network characteristics in the observed opioid 
prescription network. 
Model with main effects of patient attributes: Based the modularity score and clinical 
importance, we selected gender, age category, payment method, opioid type, number 
of prescriptions, average daily dose in MME, number of provider who wrote opioid 
prescriptions to the patient in one calendar year (categorical) and number of 
pharmacies visited during the year to fill opioid prescriptions (categorical) to include 
in the main effects model. The null hypothesis was that there was no association 
between each patient attribute and the likelihood of a patient having a connection 
through provider sharing, after controlling for all other attributes in the model. The 
results of the main effects model are summarized in Table 7. Positive coefficients (i.e., 
log odds of a connection) indicate a higher likelihood of sharing a provider with 
another patient in the network (compared to the reference level for categorical 
attributes) and negative coefficients indicate lower likelihood. The total number of 
opioid prescription filled was positively associated with an increased likelihood of 
having a shared provider. Male patients were less likely to have a shared provider in 
the network than female patients, although this difference was not statistically 
significant. Unlike patients on Medicare, patients who used Medicaid or cash 
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payments exclusively were less likely to have a shared provider with other patients in 
the opioid prescription network than patients who used commercial insurance but the 
difference was not statistically significant for the use of cash term. With only 9 
patients who used cash exclusively, there may not have been enough power to detect 
any difference. Patients who took either hydrocodone or oxycodone were more likely 
to have a shared provider in the network. A higher average daily dose of opioids was 
associated with a greater the chance of having a shared provider in the network. 
Furthermore, patients who had ≥ 4 opioid prescribers in one year were more likely to 
have at least one shared provider in the opioid prescription network than those with 
fewer providers. However, patients who filled their opioid prescriptions at ≥ 4 
pharmacies were less likely to have a shared provider in the network than those who 
used fewer pharmacies. These results are consistent with our results of network 
visualizations, mixing matrices, Pearson’s correlation coefficients and modularity 
scores.  
Model with main effects and homophily terms: We hypothesized that two patients with 
the same level of a categorical attribute, or similar number of opioid prescriptions 
filled during the study year, were equally likely to form a network connection based 
on having a shared provider. The results of the model with main effects and 
homophily terms are summarized in Table 8. Positive and significant parameter 
estimates for gender, age category, opioid type, average daily MME, and number of 
providers all indicated the presence of homophily effects for these patient attributes, 
after controlling for their main effects in the model. All homophily interaction terms 
were statistically significant at 0.05 level except for method of payment that was only 
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significant at 0.10 significance level. Use of ≥ 4 pharmacies had no homophilic 
effects. For the number of opioid prescriptions filled during the year, a negative 
coefficient indicated homophily because the absolute difference in size decreases as 
the sizes of both values in a dyad becomes more identical. The addition of homophilic 
terms did not alter the qualitative associations of the main attributes. 
Model with main effects and differential homophily terms: The results of the model 
with differential homophily terms are presented in Table 9. Overall homophilic effects 
of gender were seen mainly among females; for age mainly among patients 65 years 
and older; for opioid type among all levels especially those on 
buprenorphine/naloxone subgroup; and for number of providers mainly among those 
who saw ≤ 4 providers in a year, after controlling for other variables in the model, 
respectively. Overall homophily effects of payment type were significant at the 0.10 
level only among those on commercial insurance and there were no homophilic effects 
within other subgroups of payment method. Adjusted homophily effects of opioid 
dose and number of pharmacies did not achieve statistical significance. The addition 
of homophily terms did not alter the qualitative association of the main attributes, 
except for the subgroup of patients aged 65 and older. The model with main effects 
and differential homophily terms had a lower AIC than the baseline model and the 
model with main effects and homophilic terms. 
DISCUSSION 
This study suggests that patients in an opioid prescription network were highly 
connected. Our sample of 372 patients had 1,980 shared-provider connections and 
almost 75% of patients were connected to each other either directly or indirectly in 
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one giant component that consisted of 96% of all connections in the full network. The 
intensity of prescription opioid use and possible misuse is reflected in the number of 
prescribers in the network. There were twice as many providers as patients using 
prescription opioids. More than half the patients saw at least four providers although 
they appeared to be on a stable opioid regimen. A majority of patients were female 
and aged 45-64 years old. The underlying structure of the network was significantly 
different from that of a randomly-generated network of the same size and density. The 
random network was never designed as a model for observed networks because it 
ignores node attributes that may explain observed clustering. The distribution of the 
number of shared providers was bimodal with a second peak corresponding to 29 
shared prescribers. This may represent a group of patients who belong to a large 
medical group with many providers who cater for all the patients, including pain 
management.  
Our opioid prescription network demonstrated homophily by opioid type, 
opioid dose, age group, sources of payment and number of providers. The most 
obvious clustering on visualization was seen among patients on 
buprenorphine/naloxone. One possible explanation for this clustering is that under the 
Drug Addiction Treatment Act (DATA) of 2000, only certain qualified providers are 
authorized to prescribe buprenorphine/naloxone as medication-assisted treatment for 
people diagnosed with an opioid use disorder. Such patients are more likely to seek 
certified providers in the network. Overall, 75% of patients were connected to one or 
more patients with at least one similar characteristic. Furthermore, patients with many 
shared providers were more likely to connect to each other and such patients may have 
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patterns of use consistent with potential abuse. Although older patients with more 
medical conditions tend to be on opioid therapy, they had fewer shared providers 
compared to younger patients. This may be due older patients having a stable health 
insurance and an established primary care provider who meets their medical needs.  
Centrality measures suggested that relatively few patients were at the center of the 
opioid prescription network. Similar conclusions have been drawn about providers 
using standard statistical methods.6,7 The level of connectedness was captured by 
degree and closeness centrality measures, which identified higher daily opioid dose to 
be associated with the number of shared providers (i.e., degree centrality) and 
closeness centrality, which is a measure of how quickly information emanating from 
one patient in the network could spread to other patients assuming each shared 
provider relationship offers ample opportunities to disseminate information and 
training on opioid misuse prevention.  
If network connections represent the flow of information and influence, then a 
measure of how often a patient in the network acts as a bridge between other patients 
may provide a more useful measure. Betweenness centrality assumes there is flow of 
information in a network and attempts to capture the influence of each member over 
the spread of that information. However, in calculating this measure it is assumed that 
all patients in the network have the same probability of sharing information received 
and that the information spreads around via the shortest paths. This suggests that more 
information would pass through patients with larger betweenness centralities whose 
removal from the network could disrupt the network cohesion. In practice, patients 
may not spread information at the same rate and information may not spread through 
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the shortest paths.47 Despite these limitations, betweenness centrality remains a very 
useful guide to the potential influence a network member over the flow of information 
and may serve as a useful way to identify patients for prevention and treatment 
interventions. It also has a wide range of values making it easier to distinguish 
between central and less central patient targets. Our analysis suggested that such 
intervention would seek patients with MPE or those on opioid use disorder treatment 
first. These findings support the use of multiple provider episodes as an indicator of 
potential opioid misuse.44,57,58 Additional studies are needed to evaluate the practical 
advantages of using betweenness centrality with or without MPE. This can be easily 
implemented through sequential analysis of PDMP data which were instituted or 
strengthened primarily in response to the prescription opioid epidemic. 
Our results suggest that patients on prescription opioid medications are not 
isolated from their social environment, but rather are connected to each other via 
provider sharing. Sharing an opioid prescriber may increase the probability of 
establishing a personal relationship with another patient on opioid therapy through a 
chance encounter in a physician office or the community because, unlike some other 
controlled substances, oxycodone, hydrocodone and buprenorphine/naloxone require 
an office visit for a written prescription. These relationships form a basis for 
constructing an opioid prescription network using comprehensive and reliable 
prescription information captured by the PDMP at the state-level irrespective of the 
payer. New state regulations and laws mandates quantity limits on opioid 
prescriptions. For patients requiring chronic opioid therapy, this may lead to biweekly 
or monthly office visits for opioid prescription renewals. Refills may be provided by a 
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partner in the same practice or a provider on-call. After office hours, the patient may 
visit the emergency room or a walk-in clinic for a short supply. Broadly defined, 
doctor shopping involves visiting many providers during an episode of illness, or to 
acquire controlled substances illicitly. In the context of acquiring prescription opioid 
medications for potential misuse, patients may engage in doctor shopping because of 
long waiting times for an appointment, inconvenient office hours, persistence of 
painful condition, provider attitude, or absence because of vacation.59-61 Hence, doctor 
shopping behavior may be a reflection of fragmented care in a patient with persistent 
pain. We had no clinical diagnosis information, place of service, geographic location, 
or provider specialty to impugn any diagnosis or clinical condition for opioid 
prescriptions.  
A recent social network analysis of physicians in the United States showed that 
providers tend to be connected to other providers with similar patients in a patient-
sharing network.5 Our study shows substantial clustering and assortative mixing 
driven by patient characteristics. The extent of homophily is similar to what has been 
observed in other social settings.62,63 The cross-sectional nature of our study does not 
allow us infer the reasons for preferential connections of patients using prescription 
opioid to other patients with similar characteristics. One implication of homophily is 
that it could facilitate the spread of valuable health information through targeted 
training of influential patients in the network and reduce the diffusion of risky 




The successful application of network science to a systematic problem such as 
the opioid crisis requires careful consideration of the choice of nodes and the 
connections between them to ensure clinical significance. This study demonstrates 
several advantages of using PDMP to identify connections within a network of 
patients on prescription opioid therapy. The sample for this analysis was derived from 
a statewide PDMP data which provided a unique opportunity to identify virtually all 
provider-sharing relationships among patients on prescription opioids regardless of the 
sources of payment. Because the data is collected for use in clinical decision-making 
at the point of patient care, it is assumed to be accurate and comprehensive. It provides 
data that can be used to identify patterns of opioid prescription filling that raise 
concerns for potential opioid misuse. 
LIMITATIONS 
These analyses are subject to a few limitations. First, the sharing of an opioid 
prescriber was used to infer an information sharing relationship between patients on 
prescription opioids. Patterns of provider sharing may be a reflection of fragmented 
care rather than doctor shopping of prescription opioids for illicit use. We cannot 
identify doctor shopping from prescription data because in this context doctor 
shopping often involves an illegal and covert activity. PDMP data do not reveal the 
reasons why patients obtained multiple prescriptions from so many different 
prescribers. Second, we excluded providers with very few patients or potential 
institutional providers. We have no evidence that all prescribers were licensed in the 
state for the whole calendar year and such providers may have fewer patients. Their 
removal may cause network fragmentation, fundamentally altering some of the 
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properties of the network. Third, we used a threshold of 2,400 for so-called 
institutional providers but there could have been other institutional prescribers with 
fewer patients similar to non-institutional providers. Furthermore, providers in single 
group practice are more likely to see the same patients creating a false pattern of 
doctor shopping behavior. Because our analysis did not account for the grouping of 
physician practices, there is potential for misclassification of the number of providers 
seen. Moreover, our analysis failed to capture evidence of geographic proximity, co-
visitation to providers, or community social interactions. Fourth, our data was limited 
to a single calendar year for one state with very few variables making it difficult to 
characterize the nature of the relationships. We did not account for prescription opioid 
fills across the state-lines. Indeed, PDMP data may underestimate the prevalence of 
prescription opioid misuse because it focuses on prescribers and patients ignoring 
other sources of illicit prescription opioid use, including theft, illicit drug use, and 
unlicensed internet pharmacies. Fifth, the enforcement of regulations on electronic 
filing of controlled substance fillings, merging of prescriber practices, entry and exit 
of providers and pharmacies from the market may alter the patterns of relationships 
substantially. Sixth, the usefulness of closeness centrality in observed networks is 
often limited by the existence of several components because distance between two 
patients in different components is considered infinite. In addition, the range of 
closeness centrality values is relatively narrow, making it difficult to distinguish 
between an influential and a less influential patient in the network for the purpose of 
designing interventions. Seventh, the ERGM model of characteristics associated with 
network connections, homophily and differential homophily assumes conditional 
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independence of dyads, which is largely unrealistic in practice.64 ERGM models of 
large networks perform poorly due time-consuming algorithms and non-converging 
Markov chains, and associated model degeneracy. Furthermore, nodes are assumed 
fixed and homogenous except for differences captured in available nodal attributes. 
The use of a subnetwork in which these assumptions hold limits generalizability of 
results because every network is unique due to inconsistency under sampling. 
CONCLUSIONS 
Patterns of provider sharing in a patient-based prescription opioid network, suggest 
that patients prescribed opioids may have extensive connections with other that could 
be leveraged to improve dissemination of health promotion or disruption of negative 
behaviors with the use and misuse of opioid prescriptions. The characteristics of these 
patients and the structure of the network uniting them influence their health choices. 
The analysis suggests that opioid prescribers could easily be sought by patients who 
doctor shop for prescription opioids. Interventions targeted at influential patients in the 
network may have potential to influence social norm around the use and misuse of 
prescription opioids eventually leading to reductions in opioid overdoses and opioid 
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TABLES AND FIGURES 
 
Table 1. Characteristics of Patients in an Opioid Prescription  
Network of Patients in the RI PDMP in 2015 (n=372) 
Characteristic All (N=372) LCC (N=274) 
 Mean (SD) 
Number of providers 
Number of pharmacies 
Number of opioid Rx 
Total daily MME, mg  
Age (years) 
  3.92 (1.27) 
  3.47 (0.82) 
14.36 (6.56) 







 N (%) 





























  20 (5.38) 
















































Abbreviations: LCC= largest connected component; Rx=prescription(s) 







Table 2. Summary of Characteristics of a Network of Patients and a  
Network of Providers in the RI PDMP in 2015 
Network characteristics Patient-based Network Provider-based Network 
Basic characteristics All LCC All LCC 
Number of vertices 
Number of edges 
Density  
Average degree (SD) 
Average path length 
Diameter  
Global transitivity 
Mean Local transitivity 
Assortative coefficient 
Number of components 


















































Table 3. Distribution of standardized centrality measures by patient characteristics using the largest connected component  
of the opioid prescription network 
 Quartiles of standardized centrality measures 











































































































































































































































































































































Table 4. Odds Ratios (95% CI) Associated with a Patient being Classified in the Upper Tertile of Standardized  
Centrality Measures 
 Standardized betweenness centrality Standardized degree centrality Standardized closeness centrality 
Characteristic Unadjusted OR Adjusted OR Unadjusted OR Adjusted OR Unadjusted OR Adjusted OR 
Number of opioid Rx 0.96 (0.92, 1.01) NS 1.10 (1.047, 1.155 NS 1.01 (0.96 1.05) NS 






1.90 (0.81, 4.43) 





2.88 (1.03, 8.08) 
4.46 (1.63, 12.15)  
 
Ref. 
4.27 (1.41, 12.86) 
5.12 (1.77, 14.83) 
 
Ref. 
2.02 (0.80, 5.07) 




























2.19 (0.24, 20.03) 
1.46 (0.12, 17.23) 





0.82 (0.13, 5.05) 
0.69 (0.11, 4.42) 





0.73 (0.12, 4.46) 
0.74 (0.12, 4.69) 
1.00 (0.13, 7.89) 
 
NS 





2.02 (1.21, 3.38) 
 
Ref. 
2.62 (1.49, 4.59) 
 
Ref. 





1.89 (1.13, 3.15) 
 
Ref. 
2.09 (1.21, 3.64) 
























2.92 (1.28, 6.69) 
1.23 (0.69, 2.16) 
 
Ref 
4.18 (1.73, 10.07)  
1.13 (0.63, 2.02) 
 
Ref. 
0.10 (0.01, 0.81) 
2.78 (1.56, 4.95) 
 
Ref.  
0.02 (0.00, 0.16) 
1.10 (0.52, 2.33) 
 
Ref. 
1.59 (0.67, 3.80) 
1.89 (1.06, 3.35) 
 
NS 






0.96 (0.51, 1.79) 





4.29 (2.28, 8.06) 
2.26 (1.21, 4.26) 
 
Ref. 
4.18 (1.97, 8.84) 
6.73 (2.69, 16.86) 
 
Ref. 
2.43 (1.31, 4.51) 
1.84 (0.99, 3.41) 
 
Ref. 
2.32 (1.24, 4.34) 
2.31 (1.20, 4.44) 
Abbreviations: CI=confidence interval; OR=odds ratio; Rx=prescription; MME=morphine milligram equivalent, Bup=Buprenorphine,  






Table 5.  Mixing Matrices of Categorical Patient Attributes for an Opioid Prescription  
Network of Patients 
 All, N=372  LCC, N=274 
Patient Attributes  Mixing matrix   Mixing matrix 











































   
103 (37.59) 
134 (48.91) 


























    
















  20 (0.00) 
104 (27.96) 























  15 (0.00) 
  76 (27.74) 









































   
  32 (0.00) 





















  81 (21.77) 













   
136 (49.64) 
  67 (24.45) 


















































    
187 (68.25) 








Abbreviations: LCC= largest connected component; Bup=Buprenorphine; MME=morphine milligram equivalent,  




Table 6. Clustering by Node Attribute using Modularity Score  
Node attributes Total LCC 
Gender 
Age group (years) 
Age, years (continuous) 
Payment method 
Number of providers (continuous) 
Number of providers (categorical) 
Number of pharmacies (continuous) 
Number of pharmacies (categorical) 
Type of opioid prescription used 
Number of opioid prescriptions 
Total daily dose, MME (mg) 



























































Table 7.  Main Effects Model to Estimate the Log odds of a tie between two  
patients in the Opioid Prescription Network of Patients Using the LCC 
Term Estimate  SE P-value 
Edges 
Number of opioid prescriptions 
-5.661    
0.009 
0.174  





















0.064    
















-0.468    
0.132    


















0.983   
 
 
0.092     











0.533    
0.703    
 
 











0.133    
 
 









-0.040    
 
 
0.037       
 
 
 0.284     
Abbreviations: SE=standard error; MME=morphine milligram equivalent;  
AIC=Akaike information criterion; BIC=Bayesian information criterion, 





















Table 8. Main Effects Model with Homophily Terms to Estimate  
the Log odds of a tie between two patients in the Opioid  
Prescription Network of Patients Using the LCC 
Term Estimate SE P-value 
Edges 















































































































Homophily  terms    
Number of opioid prescriptions 
Gender 
Age category 
Method of payment 
Type of opioid prescription 
Average daily MME, mg 
Number of prescribers 

























Abbreviations: SE=standard error; MME=morphine milligram equivalent;  




Table 9. Main Effects Model with Differential Homophily Terms to Estimate the Log odds of a tie between  
two patients in the Opioid Prescription Network of Patients Using the LCC  
 Main effects  Differential homophily 
Term Estimate SE P-value  Estimate SE P-value 
Edges 
Number of opioid prescriptions 
-9.485 
0.031   
0.412 
0.004             
< 0.001 
< 0.001 
               NA 
-0.060    
             NA 











0.059       
 
 
 0.110     
  














-0.071    
-0.744    
 
Ref. 
0.126      
0.096      
 
 
0.576    
< 0.001 
  
-0.058    
0.152    
0.505   
 
0.148       
0.139       
0.264       
 
0.697     
0.273 








-0.304       
0.349    
-0.031    
 
Ref. 
0.136       
0.151       





0.852     
  
0.263    
-0.480    
-0.152    
0.774    
 
0.159       
0.740       
0.179       
1.097       
 
0.098 
0.516     
0.397     
0.480     






1.760    
2.661    
 
Ref. 
0.138       







0.919   
-0.719       
 
0.327       
0.315      











0.447    
0.725   
 
Ref. 
0.088       






0.083    
0.151    
0.028    
 
0.118  
0.118       
0.130            
 
0.480     
0.202     
0.831     





0.642    
 
Ref. 





1.104    
NA 
 










-0.127    
 
Ref. 
0.086       
 
 
0.139     
  
-0.122    
NA 
 
0.112       
NA 
 
0.273     
NA 
Abbreviations:  NA=not applicable; SE=standard error; MME=morphine milligram equivalent;  






















Figure 1. Study Sample Selection Flowchart showing number of patients, providers, and 










































































 1 2 3 4 5 6 
1 1 1 0 1 2 1 1 1 1 0 
2 1 0 0 2 1 1 0 0 0 0 
3 0 1 0 3 1 0 1 1 1 0 
4 0 1 1 4 1 0 1 2 2 1 
5 0 1 1 5 1 0 1 2 2 1 
6 0 0 1 6 0 0 0 1 1 1 
 
Figure 2: Matrix illustration of the construction of a simple network. Bipartite 
incidence matrix, A (left panel) shows the relation “prescribed opioid analgesic(s) to” 
and the one-mode projection adjacency matrix B (right panel) shows the provider-
sharing relationships between patients. One-mode projection of the bipartite network 





Figure 3. Schematic illustrating a projection from a two-mode to a one-mode network. 
Bipartite network graph of “prescribed opioid analgesic(s) to” relation for 3 providers 
(X, Y, Z) and 6 patients (1-6) [left panel] and a unipartite network graph of “shares a 















Figure 4. Four depictions of the full patient network: (a) Full network with few isolates 










Figure 5. Four depictions of the largest connected component: (a) The largest connected 
component with few clusters; (b) clustering by age category; (c) clustering by sex; and 






Figure 6: Ego-centric network around the most influential patient (# 24) identified by 
degree, closeness, and betweenness centrality measures. This ego-centric network is 







Figure 7. Degree distribution in original scale (top panels), log-log scale (middle panels), 
and the average neighbor degree versus vertex degree on a log-log scale (bottom panels) 






Figure 8: Plots of degree and shared partnerships (DSP and ESP) in the largest connected 
component of the network (left) and a randomly generated network of the same size and 
density (right). Abbreviations: DSP=dyad-wise shared partners, ESP= edgewise shared 





Figure 9: Number of triangles in 1000 networks simulated based on the null model of the 


















FUTURE RESEARCH WORK 
In the future we plan to incorporate structural properties of the observed opioid network 
as model covariates thereby allowing the observed network to be conditioned on 
observed degree distribution and level of transitivity. This will be implemented in R 
using a Bayesian approach which exhibits better convergence properties than non-
Bayesian method used in this analysis. We also plan to analyze corresponding provider- 
and pharmacy-based networks where connections between providers or pharmacies 
represent patient-sharing. These analyses will also use centrality measures to identify the 
most influential providers and pharmacies and evaluate whether patterns of opioid 































A. NETWORK CHARACTERIZATION AND MEASUREMENTS 
 
This Technical Appendix provides statistical formulations of key terms used in this 
thesis. The notations and definitions are adapted from Kolaczyk.1 In general, let 
uppercase letters denote random variables and lowercase denote realizations of those 
random variables. We assume the observed network is fixed and does not vary over time. 
We also assumed that we ascertained the full network sample.  
 
Defining a Network: A graph G = (V, E) is a mathematical structure consisting of a set 
V of vertices or nodes and a set E of edges or links, where elements of E are unordered 
pairs {u,v} of distinct vertices u,v ∈ V for an undirected graph. The number of vertices Nv 
= |V| and the number of edges Ne = |E| are called the order and size of the graph G, 
respectively. A graph H = (VH, EH) is a subgraph of another graph G = (VG, EG) if VH ⊆ 
VG and EH ⊆ EG. An induced subgraph of G is a subgraph  = ( , ), where ⊆ V is a 
pre-specified subset of vertices and ⊆ E is the collection of edges to be found in G 
among that subset of vertices. A simple graph has no edges for which both ends connect 
to a single vertex (i.e., no loops) and no pairs of vertices with more than one edge 
between them (i.e., no multi-edges). Two vertices u,v ∈ V are said to be adjacent if joined 
by an edge in E, and two edges e1,e2 ∈ E are adjacent if joined by a common endpoint in 
V. A vertex v ∈ V is incident on an edge e ∈ E if v is an endpoint of e.  
A network therefore consists of a set of nodes and the relationships (ties, links, 
edges, connections) among them. The relationship can be directed or undirected and 




3 nodes form triads. These dyads and triads can be linked or unlinked. A group of k 
nodes taking a star format with a node at the center linked to all others in the group is 
called k-star.  An undirected network has two types of dyads (null or present) and four 
types of triads defined by the number of connected edges (0, 1, 2 or 3) and may have a 3-
star, 4-star, and 5-star formats. We also distinguish edgewise shared partnership (ESP) 
and dyad-wise shared partnership (DSP). A DSP is a linked or unlinked dyad where both 
members of the dyad are linked to a third network member. ESP is a subset of DSP with 
a linked dyad in which both members of the dyad also have a link to a third network 
member. The distribution of ESP in a network shows how many dyads have one shared 
partner, two shared partners, and so on. Similarly, the distribution of DSP shows the 
number of dyads in the network with one shared partner, two shared partners, and so on. 
 A bipartite network is a graph G = (V, E) such that the vertex set V may be 
partitioned into two disjoint sets, say V1 and V2, and each edge in E has one endpoint in 
V1 and the other in V2. Specifically, a graph G1 = (V1, E1) may be defined on the vertex 
set V1 by assigning an edge to any pair of vertices that both have edges in E to at least 
one common vertex in V2. Similarly, a graph G2 may be defined on V2. 
Several notions are related to the concept of movement around a graph. A walk on a 
graph G, from v0 to vl, is an alternating sequence {v0, e1, v1, e2, . . . ,vl−1, el , vl}, where the 
endpoints of ei are {vi−1, vi}. The length of this walk is said to be . A trail is a walk 
without repeated edges and a path is a trail without repeated vertices. A vertex v in a 
graph G is said to be reachable from another vertex u if there exists a walk from u to v. 
The graph G is said to be connected if every vertex is reachable from every other. A 




length of the shortest path(s) between the vertices (which we set equal to infinity if no 
such path exists). The diameter of the graph is the value of the longest distance in a 
graph. 
  Algebraic graph theory has several applications in social network analysis. The 
connectivity of a graph G may be captured and stored in an Nv×Nv binary, symmetric, 
adjacency matrix A with entries:   
Ai j =  
where A is non-zero for entries whose row-column indices correspond to vertices in G 
joined by an edge, and zero, for those that are not. The row sum Ai+ = Σj Ai j is equal to 
the degree di of vertex i. and by symmetry, Ai+ = A+i.  The structure of a graph G may 
also be captured in an Nv×Ne binary, incidence matrix B with entries: 
 
Suppose that G = (V, E) is a graph corresponding to an observed social network among 
individuals i ∈ V, with a social tie between individuals i, j ∈ V indicated by an edge {i, j} 
∈ E. Let Yi j = Yji = 1 if {i, j} ∈ E, and zero if not. Y = [Yi j] is the adjacency matrix for G, 
and treated as a random matrix.  
 
Modularity: The process of community detection can be approached as an optimization 
problem using computational algorithms developed for studying similar networks.2,3 The 
algorithm detects subgroups within networks that are more inter-connected than would be 
expected by chance alone.3-5 In our example, each provider was assigned to a single 
community, such that communities are comprised of distinct, non-overlapping groups of 




high nodal degree are more likely to be connected than those with low nodal degree 
thereby maintaining the expected degree distribution of the network.4 The optimization 
process involves the maximization of the quantity: 
, 
where  is nonzero if and only if node  and  are connected by a tie, and its value 
quantifies the number of providers the two patients share;  is the degree of node ,  is 
the number of edges in the network (or their total weight in weighted networks),  is the 
community assignment of node , and  is the Kronecker delta which is equal to 1 
if the arguments are identical, otherwise it is zero.  We used the greedy  optimization 
method which has been shown to perform well for a variety of networks6.  
 
Centrality measures: A patient that is connected to many other patients in a network is 
in a prominent or influential position within the network. This simplest measure of 
centrality is based on the notion that a patient with more direct connections in the 
network is more influential than one with fewer or no connections at all. The degree dv of 
a vertex v, in a network graph G = (V, E), is the number of edges in E incident upon v, 
that is, at distance one and mean degree is the average degree of all patients in the opioid 
network. Vertex degree is arguably the most widely used measure of vertex centrality. In 
our setting, the patients with higher degrees are more central because in many social 
settings people with more connections tend to be more influential. A patient’s degree is 
the total number of other patients within the network who are connected to the patient 
through provider sharing. Degree centrality we can be standardized by dividing by the 




Given a network graph G, we define fd to be the fraction of vertices v ∈ V with degree dv 
= d. The collection {fd}d≥0 is called the degree distribution of G. The degree distribution 
provides a summary of the connectivity in the graph.  
Another notion of a ‘central role in the network’ is that a vertex be ‘close’ to many other 
vertices. The standard approach, introduced by Sabidussi, is to let the centrality vary 
inversely with a measure of the total distance of a vertex from all others.7  
cl(v) = , 
where dist(v,u) is the geodesic distance between the vertices u,v ∈ V. Using this 
formulation, the more central a node is, then the lower its total distance to all other nodes. 
For comparison across networks and with other centrality measures, this measure is 
normalized or standardized to lie in the interval [0,1], through multiplication by a factor 
Nv−1. 
Betweenness centrality is based upon the perspective that importance relates to 
where a vertex is located with respect to the paths in the network graph. If we assume 
those paths as the routes by which communication and other exchanges takes place, 
vertices that sit on many paths are likely more critical to the communication and other 
dissemination processes. Betweenness centrality measures are aimed at summarizing the 
extent to which a vertex is located ‘between’ other pairs of vertices. This is defined as the 
proportion of times the provider lies on the shortest paths in the network. A patient is 
central in the network if he/she is located between many non-adjacent patients on their 
geodesics (shortest) paths. The most commonly used betweenness centrality, introduced 
by Freeman,8 is defined as   




where σ (s, t|v) is the total number of shortest paths between s and t  that pass through v, 
and σ (s, t) = Σvσ (s, t|v). In the event that shortest paths are unique, cB(v) just counts the 
number of shortest paths going through v. This centrality measure can be normalized 
through division by a factor of (Nv−1)(Nv−2)/2. 
 
Network cohesion: The definition of network cohesion depends on the context. 
Generally, network cohesion refers to the extent to which subsets of nodes are connected 
to each other to form triads, components, clusters, and communities. 
Network density: For a graph G with no self-loops and no multiple edges, the density of a 
subgraph H = (VH, EH) is 
den(H) =  
The value of den(H) lies between zero and one.  
Clustering coefficient and transitivity: A triangle is a complete subgraph of order three. A 
connected triple is a subgraph of three vertices connected by two edges. A measure of the 
frequency with which connected triples form closed triangles provides some indication of 
the extent to which edges are ‘clustered’ in the graph. Let  denote the number of 
triangles in G into which v ∈ V falls, and τ3(v), the number of connected triples in G for 
which the two edges are both incident to v.  The local clustering coefficient, den(Hv) can 
be re-expressed as cl(v) =  for those vertices v with τ3(v) > 09. The 
corresponding clustering coefficient for G takes the form:  
cl(G) = , 




The clustering coefficient is the ratio of total the number of connections that exist among 
neighbors of the patient in the network to the total number of potential connections that 
could exist if they were completely connected.  It is used to describe the extent to which 
network neighbors of a particular patient are directly connected to each other and 
interpreted as the probability that any two randomly selected neighbors of a particular 
patient in the network are connected to each other. 
Assortativity and mixing: Assortative mixing is the selective linking among 
vertices, according to a certain characteristic(s), and measures that quantify the extent of 
assortative mixing in a given network have been referred to as assortativity coefficients. 
Suppose that each vertex in a graph G can be labeled according to one of M categories. 
Let fij be the fraction of edges in G that join a vertex in the ith category with a vertex in 
the jth category; denote the ith marginal row and column sums of the resulting matrix f by 
fi+ and f+i, respectively. We then define the assortativity coefficient ra to be 
ra = . 
The value ra is equal to zero when the mixing in the graph is no different from that 
obtained through a random assignment of edges that preserves the marginal degree 
distribution. Similarly, it is equal to one when there is perfect assortative mixing (i.e., 
when edges only connect vertices of the same category). When the mixing is perfectly 
disassortative, the value takes its minimum value, that is, every edge in the graph 







B. The Exponential Random Graph Model (ERGM) 
A discrete random vector Z is said to belong to an exponential family if its probability 
mass function may be expressed in the form 
, 
where θ ∈  is a p×1 vector of parameters, g(·) is a p-dimensional function of z, and ψ(θ 
) is a normalization term, ensuring that Pθ (·) sums to one over its range. The class of 
discrete exponential families includes many familiar distributions, such as the binomial, 
geometric, and Poisson. In the case of continuous exponential families, where an 
analogous form of the equation holds for probability density functions, examples include 
the Gaussian and chi-square distributions.  
Consider G = (V, E) as a random graph. Let Yij =Yji be a binary random variable 
indicating the presence or absence of an edge e ∈ E between the two vertices i and j in V. 
The matrix Y = [Yij] is thus the (random) adjacency matrix for G. Denote by y = [yij] a 
particular realization of Y. An exponential random graph model is a model specified in 
exponential family form for the joint distribution of the elements in Y. An ERGM takes 
the form 
Pθ (Y = y) = , 
where the following conditions hold: 
(i) each H is a configuration is a set of possible edges among a subset of the vertices in G; 
(ii) gH(y) = , and is either one if the configuration H occurs in y, or zero, 
otherwise; 
(iii) a non-zero value for θH means that the Yij are dependent for all pairs of vertices {i, j} 




(iv) κ =κ(θ ) is a normalization constant, where 
κ(θ) = . 
The summation in the previous equation is over all possible configurations H. Note that 
this model implies a certain (in)dependency structure among the elements in Y. 
Generally, such assumptions specify that the random variables {Yij}(i,j)∈A  are independent 
of , conditional on the values of , for given index sets A ,B, and 
C .  
Bernoulli or Simple Random Graph: The simple random graph model randomly 
distributes ties or connections among network members based on the same specified 
probability.10,11 Network density or the probability of a tie occurring is the proportion of 
observed ties out of all possible ties: 
den(H) =  
This calculation assumes that ties are independent and identically distributed and ignores 
the attributes of network members that may influence the probability of a tie. Suppose we 
specify that, for any given pair of vertices, the presence or absence of an edge between 
that pair is independent of the status of possible edges between any other pairs of 
vertices. That is, for each pair {i, j}, we assume that Yij is independent of  , for any 
{ } {i, j}. This assumption implies that θH = 0 for all configurations H involving 
three or more vertices. In this case, the only relevant functions gH are those of the form: 
gH(y) = gij(y) = yij, and the ERGM reduces to   
Pθ (Y = y) = , 




pij = exp(θij)/[1+exp(θij)] . 
However, this entails a model with  parameters, which is likely far too parameterized 
for many data sets. 
In order to reduce the total number of parameters, it is common to impose an 
assumption of homogeneity across certain vertex pairs. For example, assuming 
homogeneity across all of G (i.e., θij ≡θ , for all {i, j}) yields 
Pθ (Y = y) = , 
where L(y) = Σi,j yij = Ne is the number of edges in the graph. In this case, the Bernoulli 
random graph model is recovered, with p = exp(θ )/[1+exp(θ )] . 
Assumptions of complete independence among possible edges are largely 
untenable in practice. In general, Bernoulli-like random graphs lack the ability to 
reproduce many of the most basic structural characteristics observed in most real-world 
networks. However, the simple random graph model provides a baseline to compare with 
more complex models and assess improvements in model fit using simulation methods. 
Markov Random Graphs: Frank and Strauss introduced the notion of Markov 
dependence for network graph models, which specifies that two possible edges are 
dependent whenever they share a vertex, conditional on all other possible edges, and 
independent if they do not.12 That is, the presence or absence of {i, j} in the graph will 
depend upon that of {i,k}, for a given k j, even given information on the status of all 
other possible edges in the network. A random graph G arising under Markov 
dependence conditions is called a Markov graph. This model was extended by assuming a 
more general conditional dependence among ties in a network (i.e., two connections are 




network does not equal the product of their marginal conditional probabilities, given all 
other network ties.) Under an assumption of homogeneity, Frank and Strauss showed that 
G is a Markov graph if and only if Pθ (·) may be expressed as 
Pθ (Y = y) = , 
where S1(y) = Ne is the number of edges, Sk(y) is the number of k-stars, for 2 ≤ k ≤ Nv−1, 
and T(y) is the number of triangles. The statistics Sk in and T, can be correlated. We see 
from the definitions of the statistics Sk and T that Markov dependence results are 
explicitly parameterized to account for some effects of transitivity.  
 In practice, it is common to include star counts Sk no higher than k=2 or at most 
k=3, by setting  =…= =0. This often leads to model degeneracy. Inclusion of a 
large number of higher order terms does not solve this problem. Partial conditional 
dependence assumption has been proposed to address issues of degeneracy. For example, 
Snijders et al proposed a solution by imposing a parametric constraint of the form 
 upon the star parameter, for all k ≥ 2, for some  larger than one.13 This 
tactic combines all k-star statistics Sk(y), for k ≥ 2, into a single alternating k-star statistic 
of the form 
 
and weighting that statistic by a single parameter θAKS that takes into account the star 
effects of all orders simultaneously. The alternating signs allow the counts of k-stars of 
successively greater order to balance each other, rather than simply ballooning. We often 
assume that dependence between ties that do not share a node is due to the presence of 




linear terms are often added to the model: geometrically weighted degree (GWD), 
geometrically weighted DSP (GWDSP), and geometrically weighted ESP (GWESP). The 
statistic AKSλ (y) is a linear function of GWD count. The GWD term is designed to 
account for the decreasing degree distribution in observed networks while GWESP term 
is designed to account for clustering in observed networks. Finally, the GWDSP term 
accounts for the number of dyads with shared partners, often found within clusters in the 
network. 
 
C. Constructing the Exponential Random Graph Models 
Several packages are available for estimating network models. Our analysis was 
conducted in R-statnet, a suit of packages for building ERGMs in R. We first employed 
the null model which corresponds to the simple random graph model and can be written 
as: 
. 
The model was estimated by maximum likelihood estimation and served as a comparator 
for assessing model fit as more useful and complex models were constructed.  
Adding attributes: We first considered whether the addition of node attributes influenced 
the likelihood of a tie in the network. These nodal attributes accounted for the 
characteristics of each individual network member. To examine the effects of these 
attributes on the likelihood of a tie, these attributes were added to the model as main 
effects. The null and alternate hypotheses are: 





Ha: There is association between node attribute and the likelihood of a patient to form 
ties. 
In statnet, categorical and continuous main effects are added using nodefactor and 
nodecov(), respectively. Nodefactor main effect term adds multiple statistics to the model 
output, each corresponding to the number of times a node with the specified attribute is at 
one end of an edge. The  corresponding to a categorical node attribute can be 
summarized as follow: 
 
The reference group which is omitted in the output can be changed using the base 
argument. 
The nodecov main effect term adds one network statistic to the output that sums the 
attribute of interest for the two nodes in a dyad.  
Interaction terms for nodal attributes to account for the attributes of both members of a 
dyad in the network. Homophily interaction terms were included in the model using 
nodematch. Differential homophily was requested by specifying diff=TRUE after the 
name of the attribute in a nodematch term. The homophily change statistics is defined as: 
 
And the differential homophily change statistics is as: 
 
A potential limitation is that models that include the interaction terms are dyadic 
independence models which assume that each dyad is independent of all other dyads in 




Model fit and diagnostic assessments: Model fit assessment involves a systematic 
examination of how well the model actually captures the observed network structures 
being modeled. We compared models using the statistical measures of log-likelihood and 
the related deviance (-2LogL), the Akaike information criterion (AIC), or the Bayesian 
information criterion (BIC). The log-likelihood is calculated by summing the difference 
between predicted probabilities of  and the observed value of   
 
The deviance is a measure of lack of fit and a larger deviance indicates a greater the lack 
of fit. The deviance gets smaller as more parameters are added to the model. The AIC and 
BIC account for this by penalizing models with more parameters that do not improve the 
model fit.  
AIC = Deviance + 2p, 
BIC = Deviance + p*2ln(N), 
where p is the number of parameters and N is the network size.   
Both values of the AIC and BIC were used to compare nested and non-nested models. 
These measures of model fit were developed for the analysis of data that are assumed to 
meet the independence of observation assumption. The null, main effect, and homophily 
models which assume dyadic independence were compared using deviance, AIC, and 
BIC. Models to account for non-uniform degree distribution and transitivity resulting 
from complex of dependence in observed social networks GWD, GWESP, and GWDSP 
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